Skip to main content
. 2013 Jan 1;3(1):e23897. doi: 10.4161/biom.23897

graphic file with name biom-3-e23897-g1.jpg

Figure 1. Strategies for in vivo secretion of therapeutic antibodies: direct injection of genetic material using non-viral or viral vectors (in vivo gene therapy), and implantation of genetically modified cells (ex vivo gene therapy).